1. Phase II trial of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma after disease progression on sorafenib. (25th August 2020) Authors: El Dika, Imane; Capanu, Marinela; Chou, Joanne F.; Harding, James J.; Ly, Michele; Hrabovsky, Anna D.; Do, Richard K.G.; Shia, Jinru; Millang, Brittanie; Ma, Jennifer; O'Reilly, Eileen M.; Abou‐Alfa, Ghassan K. Journal: Cancer medicine Issue: Volume 9:Number 20(2020) Page Start: 7453 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Phase II trial of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma after disease progression on sorafenib. (25th August 2020) Authors: El Dika, Imane; Capanu, Marinela; Chou, Joanne F.; Harding, James J.; Ly, Michele; Hrabovsky, Anna D.; Do, Richard K.G.; Shia, Jinru; Millang, Brittanie; Ma, Jennifer; O'Reilly, Eileen M.; Abou‐Alfa, Ghassan K. Journal: Cancer medicine Issue: Volume 9:Number 20(2020) Page Start: 7453 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗